1 June 1999
D.B. De Laney, G.A. Tannock, R.J. Condron and G. Underwood
Royal Melbourne Institute of Technology
The findings from three trials conducted to assess the efficacy of the newly developed RMIT vaccine against Marek's disease are detailed in the report on this project.